Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

Dose Recommendation ◽

Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India

Papillomavirus Research ◽

10.1016/j.pvr.2018.03.008 ◽

2018 ◽

Vol 5 ◽

pp. 163-171 ◽

Cited By ~ 9

Author(s):

Neerja Bhatla ◽

Bhagwan M. Nene ◽

Smita Joshi ◽

Pulikottil O. Esmy ◽

Usha Rani Reddy Poli ◽

...

Keyword(s):

Cohort Study ◽

Human Papillomavirus ◽

Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up

Vaccine ◽

10.1016/j.vaccine.2018.08.009 ◽

2019 ◽

Vol 37 (27) ◽

pp. 3617-3624 ◽

Cited By ~ 10

Author(s):

Lihui Wei ◽

Xing Xie ◽

Jihong Liu ◽

Yun Zhao ◽

Wen Chen ◽

...

Keyword(s):

Human Papillomavirus ◽

Persistent Infection ◽

Chinese Women ◽

Controlled Trial ◽

Papillomavirus Vaccine ◽

Genital Disease

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

EClinicalMedicine ◽

10.1016/j.eclinm.2020.100401 ◽

2020 ◽

Vol 23 ◽

pp. 100401 ◽

Cited By ~ 2

Author(s):

Susanne K. Kjaer ◽

Mari Nygård ◽

Karin Sundström ◽

Joakim Dillner ◽

Laufey Tryggvadottir ◽

...

Keyword(s):

Human Papillomavirus ◽

Final Analysis ◽

Nordic Countries ◽

Follow Up Study ◽

Long Term Follow Up ◽

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

International Journal of STD & AIDS ◽

10.1258/095646206778145550 ◽

2006 ◽

Vol 17 (8) ◽

pp. 517-521 ◽

Cited By ~ 55

Author(s):

Matti Lehtinen ◽

Dan Apter ◽

Gary Dubin ◽

Elise Kosunen ◽

Rita Isaksson ◽

...

Keyword(s):

Human Papillomavirus ◽

Cancer Registry ◽

Vaccine Efficacy ◽

Adolescent Women ◽

Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine

Contemporary Clinical Trials ◽

10.1016/j.cct.2016.10.006 ◽

2017 ◽

Vol 52 ◽

pp. 54-61 ◽

Cited By ~ 11

Author(s):

Alain Luxembourg ◽

Susanne K. Kjaer ◽

Mari Nygard ◽

Misoo C. Ellison ◽

Thomas Group ◽

...

Keyword(s):

Human Papillomavirus ◽

Safety Study ◽

Long Term Follow Up ◽

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up

Vaccine ◽

10.1016/j.vaccine.2018.12.030 ◽

2019 ◽

Vol 37 (6) ◽

pp. 889-897 ◽

Cited By ~ 6

Author(s):

Wen Chen ◽

Yun Zhao ◽

Xing Xie ◽

Jihong Liu ◽

Jingran Li ◽

...

Keyword(s):

Clinical Trial ◽

Human Papillomavirus ◽

Chinese Women ◽

Controlled Clinical Trial ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries

Clinical Infectious Diseases ◽

10.1093/cid/cix797 ◽

2017 ◽

Vol 66 (3) ◽

pp. 339-345 ◽

Cited By ~ 49

Author(s):

Susanne K Kjaer ◽

Mari Nygård ◽

Joakim Dillner ◽

J Brooke Marshall ◽

David Radley ◽

...

Keyword(s):

Human Papillomavirus ◽

Nordic Countries ◽

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

Yearbook of Urology ◽

10.1016/j.yuro.2013.06.009 ◽

2013 ◽

Vol 2013 ◽

pp. 121-122

Author(s):

D.E. Coplen

Keyword(s):

Cohort Study ◽

Human Papillomavirus ◽

Vaccine Effectiveness ◽

National Cohort ◽

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up

Papillomavirus Research ◽

10.1016/j.pvr.2020.100203 ◽

2020 ◽

Vol 10 ◽

pp. 100203 ◽

Cited By ~ 2

Author(s):

Sven-Eric Olsson ◽

Jaime Alberto Restrepo ◽

Julio Cesar Reina ◽

Punnee Pitisuttithum ◽

Angels Ulied ◽

...

Keyword(s):

Human Papillomavirus ◽

Interim Analysis ◽

Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.16429 ◽

2020 ◽

Author(s):

C Acuti Martellucci ◽

S Nomura ◽

D Yoneoka ◽

P Ueda ◽

JML Brotherton ◽

...

Keyword(s):

Cervical Cancer ◽

Cohort Study ◽

Human Papillomavirus ◽

Cancer Screening ◽

Cervical Cancer Screening ◽

Screening Programme ◽

Cancer Screening Programme ◽

Cervical Cancer Screening Programme ◽